IL-32 production from lung adenocarcinoma cells is potentially involved in immunosuppressive microenvironment
Medical Molecular Morphology · 2024
DOI: 10.1007/s00795-023-00378-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Molecular Morphology, 2024. Verfasst von Shukang Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Kumamoto Chuo-ku, Kumamoto, 860-8556, Japan. Hauptthemen laut MEDLINE: Tumor Microenvironment, Interleukins, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science London.
Abstract (Originalsprache)
Interleukin 32 (IL-32) is a proinflammatory cytokine secreted from several kinds of cancer cells. In the present study, we investigated the significance of IL-32 in lung adenocarcinoma by immunohistochemistry and bioinformatics analysis. IL-32 was positive in cancer cells of 21 cases (9.2%) of total 228 cases. Increased IL-32 gene expression was linked to worse clinical course in TCGA analysis, however, IL-32 expression in immunohistochemistry was not associated to clinical course in our cohort. It was also found that high IL-32 expression was seen in cases with increased lymphocyte infiltration. In vitro studies indicated that IFN-γ induced gene expression of IL-32 and PD1-ligands in lung adenocarcinoma cell lines. IL-32, especially IL-32β, also induced overexpression of PD1-ligands in human monocyte-derived macrophages. Additionally, Cancer-cell-derived IL-32 was elevated by stimulation with anticancer agents. In conclusion, IL-32 potentially induced by inflammatory conditions and anticancer therapy and contribute to immune escape of cancer cells via development the immunosuppressive microenvironment. IL-32 might be a target molecule for anti-cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Kumamoto Chuo-ku, Kumamoto, 860-8556, Japan.
- Department of Thoracic Surgery and Breast Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
- Department of Pediatric Surgery and Transplantation, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
- Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Kumamoto Chuo-ku, Kumamoto, 860-8556, Japan. ycomo@kumamoto-u.ac.jp.
- Center for Metabolic Regulation of Healthy Aging, Kumamoto University, Kumamoto, Japan. ycomo@kumamoto-u.ac.jp.
- Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Förderung
- Japan Society for the Promotion of Science London
Zitieren
APA
Zhao, S., Li, L., Komohara, Y., Matsubara, E., Shinchi, Y., Adawy, A., Yano, H., Pan, C., Fujiwara, Y., Ikeda, K., Suzu, S., Hibi, T., & Suzuki, M. (2024). IL-32 production from lung adenocarcinoma cells is potentially involved in immunosuppressive microenvironment. Medical Molecular Morphology. https://doi.org/10.1007/s00795-023-00378-5
Vancouver
Zhao S, Li L, Komohara Y, Matsubara E, Shinchi Y, Adawy A, et al. IL-32 production from lung adenocarcinoma cells is potentially involved in immunosuppressive microenvironment. Medical Molecular Morphology. 2024. doi:10.1007/s00795-023-00378-5
BibTeX
@article{Zhao2024,
author = {Zhao, Shukang and Li, Lianbo and Komohara, Yoshihiro and Matsubara, Eri and Shinchi, Yusuke and Adawy, Ahmad and Yano, Hiromu and Pan, Cheng and Fujiwara, Yukio and Ikeda, Koei and Suzu, Shinya and Hibi, Taizo and Suzuki, Makoto},
title = {IL-32 production from lung adenocarcinoma cells is potentially involved in immunosuppressive microenvironment},
journal = {Medical Molecular Morphology},
year = {2024},
doi = {10.1007/s00795-023-00378-5}
}
EUVIMED